Neonatal Nonketotic Hyperglycinemia: A Severe Case With Prenatal Indicators and Comprehensive Review of Recognition and Management
ABSTRACT Nonketotic hyperglycinemia (NKH), also known as glycine encephalopathy, is a rare inherited neurometabolic disorder caused by a deficiency in the glycine cleavage enzyme system (GCS), leading to the pathological accumulation of glycine in blood and cerebrospinal fluid (CSF). This case repor...
Saved in:
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2025-01-01
|
Series: | Clinical Case Reports |
Subjects: | |
Online Access: | https://doi.org/10.1002/ccr3.70035 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832589908109164544 |
---|---|
author | Samaneh Parviz Dariush Hooshyar |
author_facet | Samaneh Parviz Dariush Hooshyar |
author_sort | Samaneh Parviz |
collection | DOAJ |
description | ABSTRACT Nonketotic hyperglycinemia (NKH), also known as glycine encephalopathy, is a rare inherited neurometabolic disorder caused by a deficiency in the glycine cleavage enzyme system (GCS), leading to the pathological accumulation of glycine in blood and cerebrospinal fluid (CSF). This case report details a neonate presenting with central apnea, profound hypotonia, and refractory seizures, alongside prenatal findings of polyhydramnios and hiccup‐like fetal movements, all strongly suggestive of severe NKH. Diagnostic evaluation confirmed markedly elevated glycine levels in serum and CSF, with a CSF‐to‐plasma glycine ratio exceeding 0.08, and ruled out alternative causes of hyperglycinemia. Brain MRI revealed characteristic malformations, corroborating the diagnosis of severe NKH. Treatment included anticonvulsants for seizure management, sodium benzoate for glycine reduction, and NMDA receptor antagonists (ketamine and dextromethorphan) to modulate neurotoxicity. Despite these therapies, the patient demonstrated poor neurodevelopmental outcomes, with rapid progression to severe impairment. This case highlights the significance of early identification, precise diagnosis, and a comprehensive care strategy in managing NKH, aiming to enhance patient outcomes and quality of life. |
format | Article |
id | doaj-art-5aabd5008a1f469994c6779f93a10c45 |
institution | Kabale University |
issn | 2050-0904 |
language | English |
publishDate | 2025-01-01 |
publisher | Wiley |
record_format | Article |
series | Clinical Case Reports |
spelling | doaj-art-5aabd5008a1f469994c6779f93a10c452025-01-24T05:08:46ZengWileyClinical Case Reports2050-09042025-01-01131n/an/a10.1002/ccr3.70035Neonatal Nonketotic Hyperglycinemia: A Severe Case With Prenatal Indicators and Comprehensive Review of Recognition and ManagementSamaneh Parviz0Dariush Hooshyar1Department of Pediatrics, Clinical Research Development Center of Children's Hospital Hormozgan University of Medical Science Bandar Abbas IranStudent Research Committee, Faculty of Medicine Hormozgan University of Medical Sciences Bandar Abbas IranABSTRACT Nonketotic hyperglycinemia (NKH), also known as glycine encephalopathy, is a rare inherited neurometabolic disorder caused by a deficiency in the glycine cleavage enzyme system (GCS), leading to the pathological accumulation of glycine in blood and cerebrospinal fluid (CSF). This case report details a neonate presenting with central apnea, profound hypotonia, and refractory seizures, alongside prenatal findings of polyhydramnios and hiccup‐like fetal movements, all strongly suggestive of severe NKH. Diagnostic evaluation confirmed markedly elevated glycine levels in serum and CSF, with a CSF‐to‐plasma glycine ratio exceeding 0.08, and ruled out alternative causes of hyperglycinemia. Brain MRI revealed characteristic malformations, corroborating the diagnosis of severe NKH. Treatment included anticonvulsants for seizure management, sodium benzoate for glycine reduction, and NMDA receptor antagonists (ketamine and dextromethorphan) to modulate neurotoxicity. Despite these therapies, the patient demonstrated poor neurodevelopmental outcomes, with rapid progression to severe impairment. This case highlights the significance of early identification, precise diagnosis, and a comprehensive care strategy in managing NKH, aiming to enhance patient outcomes and quality of life.https://doi.org/10.1002/ccr3.70035antiepileptic drugsglycine encephalopathyhiccup‐like movementsneonatal nonketotic hyperglycinemiaprenatal indicators |
spellingShingle | Samaneh Parviz Dariush Hooshyar Neonatal Nonketotic Hyperglycinemia: A Severe Case With Prenatal Indicators and Comprehensive Review of Recognition and Management Clinical Case Reports antiepileptic drugs glycine encephalopathy hiccup‐like movements neonatal nonketotic hyperglycinemia prenatal indicators |
title | Neonatal Nonketotic Hyperglycinemia: A Severe Case With Prenatal Indicators and Comprehensive Review of Recognition and Management |
title_full | Neonatal Nonketotic Hyperglycinemia: A Severe Case With Prenatal Indicators and Comprehensive Review of Recognition and Management |
title_fullStr | Neonatal Nonketotic Hyperglycinemia: A Severe Case With Prenatal Indicators and Comprehensive Review of Recognition and Management |
title_full_unstemmed | Neonatal Nonketotic Hyperglycinemia: A Severe Case With Prenatal Indicators and Comprehensive Review of Recognition and Management |
title_short | Neonatal Nonketotic Hyperglycinemia: A Severe Case With Prenatal Indicators and Comprehensive Review of Recognition and Management |
title_sort | neonatal nonketotic hyperglycinemia a severe case with prenatal indicators and comprehensive review of recognition and management |
topic | antiepileptic drugs glycine encephalopathy hiccup‐like movements neonatal nonketotic hyperglycinemia prenatal indicators |
url | https://doi.org/10.1002/ccr3.70035 |
work_keys_str_mv | AT samanehparviz neonatalnonketotichyperglycinemiaaseverecasewithprenatalindicatorsandcomprehensivereviewofrecognitionandmanagement AT dariushhooshyar neonatalnonketotichyperglycinemiaaseverecasewithprenatalindicatorsandcomprehensivereviewofrecognitionandmanagement |